These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7661876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
    Krause BR, Newton RS.
    Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
    [Abstract] [Full Text] [Related]

  • 3. F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.
    Junquero D, Bruniquel F, N'Guyen X, Autin JM, Patoiseau JF, Degryse AD, Colpaert FC, Delhon A.
    Atherosclerosis; 2001 Mar; 155(1):131-42. PubMed ID: 11223434
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [Abstract] [Full Text] [Related]

  • 5. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K, Pineda G, Newton RS, Fernandez ML.
    Biochem Pharmacol; 1999 Oct 01; 58(7):1209-19. PubMed ID: 10484079
    [Abstract] [Full Text] [Related]

  • 6. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P, Kafonek S, Laurora I, Hunninghake D.
    Am J Cardiol; 1998 Mar 01; 81(5):582-7. PubMed ID: 9514454
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
    Dart A, Jerums G, Nicholson G, d'Emden M, Hamilton-Craig I, Tallis G, Best J, West M, Sullivan D, Bracs P, Black D.
    Am J Cardiol; 1997 Jul 01; 80(1):39-44. PubMed ID: 9205017
    [Abstract] [Full Text] [Related]

  • 8. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR.
    Atherosclerosis; 1996 Jan 26; 119(2):203-13. PubMed ID: 8808497
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
    Davidson M, McKenney J, Stein E, Schrott H, Bakker-Arkema R, Fayyad R, Black D.
    Am J Cardiol; 1997 Jun 01; 79(11):1475-81. PubMed ID: 9185636
    [Abstract] [Full Text] [Related]

  • 11. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ.
    Am J Cardiol; 2004 Jan 01; 93(1):31-9. PubMed ID: 14697462
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P.
    Am J Cardiovasc Drugs; 2006 Jan 01; 6(3):177-88. PubMed ID: 16780391
    [Abstract] [Full Text] [Related]

  • 13. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P, Heinonen T, Shurzinske L, Black DM.
    Atherosclerosis; 1997 Aug 01; 133(1):123-33. PubMed ID: 9258416
    [Abstract] [Full Text] [Related]

  • 14. Regulation of hepatic receptor-dependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starch-casein diet.
    Chao YS, Kroon PA, Yamin TT, Thompson GM, Alberts AW.
    Biochim Biophys Acta; 1983 Nov 29; 754(2):134-41. PubMed ID: 6317039
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.
    Telford DE, Edwards JY, Lipson SM, Sutherland B, Barrett PH, Burnett JR, Krul ES, Keller BT, Huff MW.
    J Lipid Res; 2003 May 29; 44(5):943-52. PubMed ID: 12562847
    [Abstract] [Full Text] [Related]

  • 16. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
    Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C.
    Ann Pharmacother; 2008 Jan 29; 42(1):9-15. PubMed ID: 18000162
    [Abstract] [Full Text] [Related]

  • 17. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.
    Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, März W.
    Biochem Pharmacol; 2001 Dec 01; 62(11):1545-55. PubMed ID: 11728391
    [Abstract] [Full Text] [Related]

  • 18. Correction of dyslipoproteinaemia of casein-fed rabbit by FCE 27677, a potent novel ACAT inhibitor.
    Chiari A, Lovisolo P, Fogliatto G, Fancelli D, Ghiselli G.
    Pharmacol Res; 1996 Mar 01; 33(3):181-9. PubMed ID: 8880889
    [Abstract] [Full Text] [Related]

  • 19. Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
    Rashid S, Uffelman KD, Barrett PH, Lewis GF.
    Circulation; 2002 Dec 03; 106(23):2955-60. PubMed ID: 12460878
    [Abstract] [Full Text] [Related]

  • 20. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 03; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.